Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's Disease
- Study Title
- A Study of Treatment With Pridopidine (ACR16) in Patients With Huntington's Disease
- Teva Identifier
- ACR16 C008
- ClinicalTrials.gov Identifier
- NCT00665223
- Study Status
- Completed
- Trial Condition(s)
- Huntington's Disease
- Interventions
- Drug: ACR16 | Drug: Placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 30 Years and older
- Trial Duration
- 04/01/2008 - 06/01/2011
- Phase
- Phase 3
